How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Lemtrada cost savings if eligible
If you are eligible for the Lemtrada patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Lemtrada through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Lemtrada patient assistance program?
You could receive your Lemtrada without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Lemtrada patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Lemtrada.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Lemtrada patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Lemtrada medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx a Lemtrada coupons provider?
At NiceRx, we help eligible individuals access the Lemtrada patient assistance program. This means that we are not a Lemtrada coupon, a Lemtrada discount card, or a Lemtrada copay card provider. We do not offer any medication trial offers, or free Lemtrada samples.
Can NiceRx help me get Lemtrada if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Lemtrada medication, or you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Lemtrada cost without insurance?
Lemtrada costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Lemtrada intravenous solution (10 mg/mL) will typically cost around $26,700 for 1.2 milliliters. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Lemtrada cost with insurance?
The copay of Lemtrada will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Lemtrada?
Lemtrada is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Genzyme Corporation. It contains the same active ingredient (alemtuzumab) found in Campath.
Lemtrada is a CD52-directed cytolytic monoclonal antibody used for the treatment of patients with relapsing forms of multiple sclerosis (MS). The use of Lemtrada should be reserved for patients who have had an inadequate response to two or more drugs for the treatment of MS. MS is caused by the immune system attacking healthy parts of the nervous system.
See the full prescribing information for the complete boxed warning. Lemtrada causes serious, sometimes fatal, autoimmune conditions such as immune thrombocytopenia and anti-glomerular basement membrane disease. It is recommended to monitor complete blood counts with differential, serum creatinine levels, and urinalysis with urine counts at periodic intervals for 48 months after the last dose.
Lemtrada causes serious and life-threatening infusion reactions. It must be given in a setting with appropriate healthcare facilities and personnel to manage anaphylaxis or serious infusion reactions. Patients should be aware that serious infusion reactions can also occur after the 2-hour monitoring period.
Lemtrada may also cause an increased risk of malignancies, including thyroid cancer, melanoma, and lymphoproliferative disorders. Baseline and yearly skin exams should be carried out.
Lemtrada is available only through restricted distribution under a Risk evaluation and mitigation strategy (REMS) program.
What doses of Lemtrada are available?
Lemtrada is available in injection form, in the following doses: 12 mg/1.2 mL (10 mg/mL) in a single-use vial.
Administer by intravenous infusion over 4 hours for 2 treatment courses:
- First course: 12 mg/day on 5 consecutive days
- Second course: 12 mg/day on 3 consecutive days, 12 months after the first treatment course. Premedicate with corticosteroids prior to the Lemtrada infusion for the first 3 days of each treatment course
- Administer antiviral agents for herpetic prophylaxis starting on the first day of dosing and continuing for a minimum of two months after completion of dosing or until CD4+ lymphocyte count is more than 200 cells per microliter, whichever occurs later
Always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Lemtrada active ingredients
Lemtrada contains alemtuzumab as the active ingredient.
Lemtrada side effects
The most common side effects of Lemtrada in clinical trials (incidence ≥10% and > interferon beta-1a) include:
- Rash, headache, pyrexia, flushing
- Nasopharyngitis, sinusitis, oropharyngeal pain
- Nausea, vomiting
- Increased risk of infections – urinary tract infection, upper respiratory tract infection, herpes viral infection, fungal infection, listeria, hepatitis (consider delaying initiation of treatment in patients with active infections until the infection is fully controlled)
- Urticaria, pruritus
- Thyroid gland disorders
- Arthralgia, pain in extremity, back pain
- Diarrhea, constipation, abdominal pain
- Paresthesia, dizziness
In rare instances, Lemtrada can cause more serious side effects. These can include:
- Acute acalculous cholecystitis
- Thyroid disorders
- Other autoimmune cytopenias
- Serious infections
- Progressive multifocal leukoencephalopathy (PML) – it is important that you call your doctor right away if you have any new or worsening medical problems that have lasted several days
- Swelling of lung tissue (pneumonitis) – call your doctor right away if you have shortness of breath, cough, wheezing, chest pain, or tightness, or if you are coughing up blood
Your doctor will assess the benefits of using Lemtrada against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Lemtrada to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Lemtrada drug interactions
There is currently no data for Lemtrada interactions with other medications. Tell your healthcare provider about all the medicines you take, including prescription drugs and over-the-counter medicines, vitamins, and herbal supplements.
You should not use Lemtrada if you:
- Are allergic to the active ingredient alemtuzumab
- Are allergic to any of the other ingredients in Lemtrada
- Have an infection with Human immunodeficiency virus
Talk to your doctor before using Lemtrada if you:
- Are taking any of the medications that could interact with Lemtrada
- Have bleeding, thyroid, or kidney problems
- Have a recent history of infection
- Are taking a medicine called Campath
- Have received a live vaccine in the past 6 weeks or plan to receive any live vaccines
- Are pregnant or are planning to become pregnant – you should use birth control while receiving treatment and for 4 months after your course of treatment
- Are breastfeeding or are planning to breastfeed
Lemtrada is the trademark brand name for alemtuzumab manufactured by Genzyme Corporation. A generic version of alemtuzumab is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Lemtrada savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.